Regeneron Collaborates with TriNetX to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions
Regeneron Pharmaceuticals announces a strategic collaboration with TriNetX to access de-identified electronic health records of approximately 300 million patients globally, including 170 million in the U.S. This collaboration will enable Regeneron to link these records with its extensive genomic and proteomic data, significantly expanding its datab…